Qurient Co. Ltd.

Qurient Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW1777
Market Cap
KRW193.93 B
Shares Outstanding
7.68 M
Public Float
6.27 M

Profile

Address
8/F, Tower C, PDCC Building
Seongnam GY 13487
Korea, Republic Of
Employees -
Website http://www.qurient.com
Updated 09/14/2018
Qurient Co., Ltd. engages in the development of novel therapeutics. Its research and development pipeline includes tuberculosis, atopic dermatitis, asthma and cancer. It offers drug development management and business development services.

Financials

View All

Wang-Shik Ryu
Non-Executive Director
Ki-Yean Nam
Chief Executive Officer & Director